Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideHematopoietic Stem CellsThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisCytarabineStem CellsHematopoiesisHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesNeoplasmsTissue DonorsSurvival RateWhole-Body IrradiationSurvival AnalysisTime FactorsInfectionLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountPrednisoneCarboplatinHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineBlood Cell CountFollow-Up StudiesRecombinant ProteinsBone Marrow PurgingLeukemiaBlood Transfusion, AutologousAntineoplastic AgentsLymphomaProspective StudiesCytomegalovirus InfectionsBlood CellsGraft vs Leukemia EffectFeasibility StudiesFatal OutcomeMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationLymphocyte DepletionT-LymphocytesLeukocytes, MononuclearHematologic DiseasesHistiocytosis, Non-Langerhans-CellBone MarrowOpportunistic InfectionsLivedo ReticularisHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisCyclosporineBlood DonorsBreast NeoplasmsImmunosuppressionCell SeparationMesenchymal Stem Cell Transplantation